Progress and prospects: gene therapy clinical trials (part 1)

Area of Science:

• Medical Genetics
• Molecular Biology
• Biotechnology

Background:

• Gene therapy has transitioned from preclinical research to clinical applications over the past 20 years.
• It targets a spectrum of diseases, including single-gene disorders like cystic fibrosis and Duchenne muscular dystrophy, and complex conditions such as cancer and cardiovascular diseases.
• Severe combined immunodeficiency (SCID) gene therapy represents a major success, though progress is noted across many other therapeutic areas.

Purpose of the Study:

• To provide a succinct summary and expert commentary on the current state of clinical gene therapy research.
• To highlight advancements and challenges in diverse fields of gene therapy.
• To offer insights into the future prospects of gene therapy applications.

Main Methods:

• A survey of 20 leading experts in the field of gene therapy.
• Solicitation of concise summaries and commentary on their respective areas of expertise.
• Publication of findings in a two-part series titled 'Progress and Prospect'.

Main Results:

• Expert summaries cover gene therapy progress in various disease areas.
• Commentary provides insights into current successes and ongoing challenges.
• The research consolidates expert opinions on the state of clinical gene therapy.

Conclusions:

• Gene therapy has demonstrated significant clinical progress, particularly for SCID.
• The field holds promise for treating a wide range of genetic and complex diseases.
• Expert perspectives offer a valuable outlook on future gene therapy development and application.